Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. MDxHealth SA
  6. News
  7. Summary
    MDXH   BE0003844611

MDXHEALTH SA

(MDXH)
  Report
Real-time Euronext Bruxelles  -  11:35 2022-09-23 am EDT
0.6860 EUR   -2.00%
08/29Oppenheimer Adjusts MDxHealth Price Target to $21 From $18, Maintains Outperform Rating
MT
08/26BTIG Adjusts Price Target on MDxHealth to $15 From $13, Reiterates Buy Rating
MT
08/26MDXHEALTH SA : Half-year report
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Belgium's MDxHealth To Buy Exact Sciences' Prostrate Cancer Test For $100 Million

08/03/2022 | 12:47am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
EXACT SCIENCES CORPORATION -2.74% 33.41 Delayed Quote.-57.07%
MDXHEALTH SA -2.00% 0.686 Real-time Quote.-22.22%
All news about MDXHEALTH SA
08/29Oppenheimer Adjusts MDxHealth Price Target to $21 From $18, Maintains Outperform Rating
MT
08/26BTIG Adjusts Price Target on MDxHealth to $15 From $13, Reiterates Buy Rating
MT
08/26MDXHEALTH SA : Half-year report
CO
08/25MDxHealth SA Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/25MDxHealth Reports Half Year 2022 Results
GL
08/25MDxHealth Reports Half Year 2022 Results
AQ
08/25MDXHEALTH SA : 1st-half-year results
CO
08/19Mdxhealth's New Share Capital Amount and New Number of Shares
GL
08/19Mdxhealth's New Share Capital Amount and New Number of Shares
AQ
08/19MDXHEALTH SA : Threshold crossings
CO
More news
Analyst Recommendations on MDXHEALTH SA
More recommendations
Financials
Sales 2022 40,8 M 39,7 M 39,7 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 112 M 109 M 109 M
Capi. / Sales 2022 2,74x
Capi. / Sales 2023 1,93x
Nbr of Employees 191
Free-Float 83,6%
Chart MDXHEALTH SA
Duration : Period :
MDxHealth SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MDXHEALTH SA
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,69 €
Average target price 1,20 €
Spread / Average Target 74,9%
Managers and Directors
Michael K. McGarrity Chief Executive Officer & Executive Director
Ron Kalfus Chief Financial Officer
Koen Hoffman Chairman
Miriam Reyes Executive Vice President-Operations
Joseph Sollee Chief Compliance Officer, EVP & General Counsel
Sector and Competitors
1st jan.Capi. (M$)
MDXHEALTH SA-22.22%109
MODERNA, INC.-51.32%48 368
IQVIA HOLDINGS INC.-32.86%35 330
LONZA GROUP AG-41.68%33 599
SEAGEN INC.-9.96%25 673
ALNYLAM PHARMACEUTICALS, INC.19.54%24 099